Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
1 "Fan Yang"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Pathophysiology
Article image
Deficiency of ASGR1 Alleviates Diet-Induced Systemic Insulin Resistance via Improved Hepatic Insulin Sensitivity
Xiaorui Yu, Jiawang Tao, Yuhang Wu, Yan Chen, Penghui Li, Fan Yang, Miaoxiu Tang, Abdul Sammad, Yu Tao, Yingying Xu, Yin-Xiong Li
Diabetes Metab J. 2024;48(4):802-815.   Published online February 1, 2024
DOI: https://doi.org/10.4093/dmj.2023.0124
  • 6,238 View
  • 178 Download
  • 9 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Insulin resistance (IR) is the key pathological basis of many metabolic disorders. Lack of asialoglycoprotein receptor 1 (ASGR1) decreased the serum lipid levels and reduced the risk of coronary artery disease. However, whether ASGR1 also participates in the regulatory network of insulin sensitivity and glucose metabolism remains unknown.
Methods
The constructed ASGR1 knockout mice and ASGR1-/- HepG2 cell lines were used to establish the animal model of metabolic syndrome and the IR cell model by high-fat diet (HFD) or drug induction, respectively. Then we evaluated the glucose metabolism and insulin signaling in vivo and in vitro.
Results
ASGR1 deficiency ameliorated systemic IR in mice fed with HFD, evidenced by improved insulin intolerance, serum insulin, and homeostasis model assessment of IR index, mainly contributed from increased insulin signaling in the liver, but not in muscle or adipose tissues. Meanwhile, the insulin signal transduction was significantly enhanced in ASGR1-/- HepG2 cells. By transcriptome analyses and comparison, those differentially expressed genes between ASGR1 null and wild type were enriched in the insulin signal pathway, particularly in phosphoinositide 3-kinase-AKT signaling. Notably, ASGR1 deficiency significantly reduced hepatic gluconeogenesis and glycogenolysis.
Conclusion
The ASGR1 deficiency was consequentially linked with improved hepatic insulin sensitivity under metabolic stress, hepatic IR was the core factor of systemic IR, and overcoming hepatic IR significantly relieved the systemic IR. It suggests that ASGR1 is a potential intervention target for improving systemic IR in metabolic disorders.

Citations

Citations to this article as recorded by  
  • Increased Asialoglycoprotein Receptor 1 Level in Granulosa Cell as a Potential Biomarker for Polycystic Ovary Syndrome
    Xitong Liu, Rongxia Xie, Yang Cai, Hui Lan, Jing Mu, Chen Zhang, Bo Li
    Reproductive Sciences.2026;[Epub]     CrossRef
  • Serum soluble ASGR1 concentration is elevated in patients with metabolic dysfunction-associated steatotic liver disease and is associated with adiponectin
    Jing-Ming Wang, Li-Yan Jiang, Yu-Ting Deng, Jiao-Yang Li, Heng Sun, Li Ran, Xinhua Xiao
    BMJ Open Diabetes Research & Care.2026; 14(1): e005638.     CrossRef
  • Association Analysis of the Circulating Proteome With Sarcopenia‐Related Traits Reveals Potential Drug Targets for Sarcopenia
    Simin Wen, Siqi Xu, Xizeng Zong, Shifeng Wen, Wende Xiao, Weipeng Zheng, Han Cen, Zhaohua Zhu, Jingyu Xie, Yan Zhang, Changhai Ding, Guangfeng Ruan
    Journal of Cachexia, Sarcopenia and Muscle.2025;[Epub]     CrossRef
  • Serum Soluble Asialoglycoprotein Receptor 1: A Potential Predictor Marker Linked to Type 2 Diabetes Mellitus, Demonstrating Positive Correlation With High Sensitive C-Reactive Protein
    Haifeng Zhu, Ziyi Zhong, Gaonian Zhao, Yuan Cao, Wei Liu, Yawen Guo, Jing Jin
    Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 663.     CrossRef
  • Cross-sectional, interventional, and causal investigation of insulin sensitivity using plasma proteomics in diverse populations
    Pik Fang Kho, Neil Wary, Daniela Zanetti, Fahim Abbasi, Joshua W. Knowles, Daniel J. Panyard, Katie T. Watson, Laurel Stell, Laura C. Lazzeroni, Stefan Gustafsson, Lars Lind, John R. Petrie, Themistocles L. Assimes
    Metabolism.2025; 169: 156263.     CrossRef
  • Causal Relationship Between Serum Zinc Levels and Diabetic Kidney Disease (DKD): A Plasma Proteomics Mediation Study
    Chunbo Zhao, Tingting Pan, Wei Liu, Fanqian Cheng, Xiaoxuan Zhao, Shuxin Yu, Yi Yang, Ran Zhang, Weixia Sun
    Biological Trace Element Research.2025;[Epub]     CrossRef
  • Triglyceride-glucose index and triglyceride-to-high-density lipoprotein cholesterol ratio as novel predictors of acute kidney injury: an analysis of the UK biobank
    Fangfang Zhou, Yuanyuan Wang, Youjun Xu, Lailiang Wang, Jinxia Ge, Qun Luo, Hongpeng Sun
    Renal Failure.2025;[Epub]     CrossRef
  • Proteomic Markers of Dietary Patterns, CKD Progression, and Mortality in the CRIC Study
    Valerie K. Sullivan, Jingsha Chen, Lawrence J. Appel, Sarah Schrauben, Ana C. Ricardo, Panduranga Rao, Mirela Dobre, Nishigandha Pradhan, Jing Chen, Jiang He, Hernan Rincon-Choles, Paul L. Kimmel, Casey M. Rebholz
    Clinical Journal of the American Society of Nephrology.2025;[Epub]     CrossRef
  • Experimental cell models of insulin resistance: overview and appraisal
    Ying Yang, Ting-ting Wang, Hu-ai Xie, Ping Ping Hu, Pan Li
    Frontiers in Endocrinology.2024;[Epub]     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP